Atlas Trials

An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

Clinical trial NCT01399190 · COMPLETED

Trial details

NCT number
NCT01399190
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Colorectal Cancer
Start date
2011-07-01
Primary completion
2014-02-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.